Hexarelin Maintains GH-Releasing Power Even After Repeated Dosing in Humans | Research

The takeaway

Repeated hexarelin administration maintained its GH-releasing effect, and combining hexarelin with GHRH produced a synergistic GH response greater than either alone.

Synergistic combination effect
Hexarelin plus GHRH produced a GH response greater than the sum of individual effects, confirming different mechanisms of action

What the researchers found

Hexarelin maintained GH-releasing efficacy with repeated administration, and hexarelin plus GHRH produced a synergistic GH response exceeding individual effects.

Why it matters

Tolerance is a major concern with repeated peptide use. Demonstrating that hexarelin maintains its effect with repeat dosing supports its viability as a clinical GH secretagogue.

How the study worked

Randomized, double-blind, crossover RCT with single IV boluses of hexarelin, GHRH, or hexarelin+GHRH administered as two sequential doses to assess responsivity maintenance.

What this study cannot tell us

Short-term study assessing only acute repeated doses. Long-term tolerance with daily chronic use was not assessed. Sample size and specific participant numbers not detailed in abstract.

How to read the evidence

Strong evidence from a randomized, double-blind crossover design. Short-term acute dosing protocol limits conclusions about chronic use tolerance.

When this study was published

Published in 1996, this study established key principles about hexarelin dosing and GHRP-GHRH synergy that inform current peptide protocols.

The bigger picture

The synergistic effect of hexarelin plus GHRH became a key principle in growth hormone optimization — using two agents working through different receptors produces better results than maximizing either one alone.

Questions still open

Does hexarelin maintain its effectiveness over weeks or months of daily use?
Is the hexarelin-GHRH synergy consistent across different patient populations and ages?

Common questions

What is hexarelin?

Hexarelin is a synthetic six-amino-acid growth hormone-releasing peptide. It's one of the more potent GHRPs studied and works by stimulating both the pituitary and hypothalamus to release growth hormone.

Why is the synergy with GHRH important?

Hexarelin and GHRH work through completely different receptors and signaling pathways. When combined, they activate two independent GH-release mechanisms simultaneously, producing a much larger GH pulse than either alone — like pressing both the gas pedal and releasing the brake at the same time.

Read the original research

The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.

Clinical endocrinology, 44(5), 555-62

View on PubMed ↗

Citation

Massoud, A F; Hindmarsh, P C; Matthews, D R; Brook, C G. (1996). The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.. Clinical endocrinology, 44(5), 555-62.